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Tiivistelmä - Referat – Abstract 
Forkhead box G1 proteiini (FOXG1) on transkriptiorepressori, joka osallistuu moniin eri signaalireitteihin. Se 
on aiemmalta nimeltään Brain Factor 1 (BF1) ja on tunnettu vaikutuksistaan neurogeneesiin. FOXG1 
expressoituu esiaivoissa ja kasvojen alueen hermostopienan soluissa. 
Tutkimuksen tavoitteena oli tutkia FOXG1:n osuutta otsaluiden kehityksessä hiirillä. Tämä toteutettiin Foxg1- 
mutatoidun hiirilinjalla avulla, jossa Foxg1-alleeli korvattiin Cre-rekombinaasilla. Tutkimuksessa käytettiin 
geenitekniikan menetelmiä ja luuston analyysejä. Ero mutantti alkioiden Foxg1cre/cre ja villityypin alkioiden 
Foxg1+/+ välillä löytyi. 
Foxg1cre/cre mutanttialkioiden otsaluiden ja nenäluiden alueelta löytyi poikkeavuuksia. Otsaluiden välinen 
sauma oli tähden mallinen ja otsaluut olivat kapeampia, sekä kallot olivat pienempiä Foxg1cre/cre 
mutanttialkioilla. Epämuodostumien syytä etsittiin solujen erilaistumisesta ja sitä analysoitiin EDU-
värjäyksillä. EDU-värjäykset suoritettiin kallon kehitykselle tärkeissä alkion kehityksen vaiheissa, mutta 
erilaistumisessa ei havaittu eroja. 
Foxg1-mRNA:n ekpressoitumista havaittiin esiaivoissa, mutta ei kehittyvän otsaluun mesenkyymissä. Tämä 
voi olla merkki siitä, että fenotyyppi voi johtua poikkeavuuksista esiaivojen – ja kallon mesenkyymin 
kudosinteraktiossa tai jo aiemman vaiheen poikkeavuudesta hermostopienan soluissa. 
Foxg1cre/cre mutantien ja Foxg1+/+ villityyppien välillä nähtiin poikkeavuuksia HNK1-hermostopienamarkkerin 
jakaumassa alkioissa iältään 9.5-12.5 päivää. Erot saattavat omalta osaltaan selittää kallon ja kasvojen 
alueen fenotyyppiä Foxg1cre/cre hiirillä. Hermostopienan vaelluksessa saattaa olla eroa Foxg1cre/cre ja 
villityypin Foxg1+/+ välillä. 
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1 Abstract 
Forkhead box G1 protein (FOXG1) is a transcription repressor that participates in multiple 
signaling pathways. FOXG1 formerly known as Brain factor 1 (BF1) is known for its effects 
on neurogenesis. FOXG1 is also expressed in the neural crest cells (NCC’s), specifically in 
the facial NCC’s that form the craniofacial structures.  
The aim of this study was to investigate the role of FOXG1 in the craniofacial bone 
development in mice and this was conducted by using a mouse strain with the Foxg1-gene 
targeted by Cre-recombinase (Cre), which represents Foxg1 null allele. Using a combination 
of mouse genetics, gene expression analysis and skeletal analysis was used and a difference 
was seen between mutated Foxg1cre/cre-embryos (MT) and wild type Foxg1+/+-embryos (WT). 
Abnormalities were found in the frontal region of the skull and in the nasal bones of the 
Foxg1cre/cre-embryos. The frontal suture was seen to be star shaped and wider in the mutants 
and the suture persisted after the WT suture narrowed. The frontal bones and the nasal bones 
were narrower, and the skulls were smaller in the MT – embryos compared to WT littermates. 
To analyze whether alteration in cell proliferation could account for these malformations, 
EDU-stainings at key stages of calvarial development were performed, but no abnormalities 
were found.  
Foxg1-mRNA was detected in the forebrain but not in the developing frontal bone 
mesenchyme. This might indicate that the phenotype is caused due to abnormalities possible 
in forebrain – calvarial mesenchyme tissue-tissue interactions or earlier due to abnormalities 
in the NCC’s. 
Between embryonic ages 9.5-12.5 (E9.5-E12.5), abnormalities in the distribution of the NCC 
marker HNK1 were noted in the Foxg1cre/cre mutant mice compared to Foxg1+/+ wild type. 
The differences may go some way to explain the craniofacial phenotype in these mice.  
2 Introduction 
Forkhead box G1 protein (FOXG1) is a transcription repressor that participates in multiple 
signaling pathways. Formerly, it was known as Brain factor 1 (BF1) and is known for its 
effects on neurogenesis. In humans, mutations in the gene coding FOXG1 causes FoxG1-
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syndrome (MIM #613454), which is a Rett-syndrome like disorder that effects many different 
parts of the development of head structures. These include: postnatal microcephaly, severe 
mental retardation, absent language, dyskinesia and corpus callosum hypogenesis. (1) In mus 
musculus the Foxg1cre/cre – embryos (Foxg1 null allele mice, MT) develop to term, but don’t 
survive after birth. During brain development FOXG1 is essential for telencephalic 
specialization. (2) 
FOXG1 also regulates the development of the olfactory system. There are no recognizable 
olfactory structures in Foxg1 null allele mice. (3) This is in alignment that FOXG1 affects the 
development of neurons and forebrain structures. 
Facial Neural Crest Cells (FNCC’s) emerge from the posterior diencephalon down to 
rhombomere two during neurulation. The FNCC’s migrate towards the facial area and form 
osteoblasts, chondrocytes, odontoblasts, myocytes, melanocytes, cranial parasympathetic 
neurons and their support cells, glia- and some sensory neurons. FNCC’s contribute to the 
craniofacial skeleton and the dentine and the cementine of teeth. They also form the 
musculoconnective cells to line the endothelium of the blood cells of the face and forebrain. 
During the migration FNCC’s also shield and protect the brain against the effects of the bone 
morphogenic proteins (BMP’s).(3-7) FOXG1 is expressed in the forebrain, and the neural 
crest cells (NCC’s). FOXG1 is expressed in the prosencephalic neuroepithelium and is 
involved in the segregation of telencephalon from the diencephalon. In mice, FOXG1 first 
appear in the five-somite stage at the neural plate. By the embryonic age E10.5 the 
telencephalic region is cover with FOXG1, excluding the caudal telencephalon. (4,8,9,10) 
FOXG1 controls forebrain development by regulatory WNT86. FOXG1 is regulated by FGF 
signaling and FOXG1 activity is regulated by Gli transcription factors (11). Abnormal FGF, 
WNT and HH (Gli3) signaling are known to recall in calvarial bone phenotypes inducing 
craniosynostosis and widened sutures. (12,13,14) 
The aim of this study is to investigate the role of FOXG1 in the development of the 
craniofacial skeleton. It was found that Foxg1 null allele mutant mice display a calvarial 
phenotype, the frontal suture is wider than in wild type mice and star shaped in pattern. The 
mutants also have a smaller skull and narrower nasal bones. The NCC marker HNK1 was 
found to be altered in Foxg1 mutants, suggesting that abnormalities in NCC may contribute 
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to the phenotype observed. It was also shown that FOXG1 is not expressed in the developing 
frontal bone itself, but in the adjacent underlying forebrain.  
3 Materials and methods 
3.1 Ethical issues 
All experiments were approved by the University of Helsinki (KEK14-05) and The Southern 
Finland Council of Animal Welfare and Ethics (ESAVI/10370/04.10.07/2014). 
3.2 Mice 
The study was conducted using a mouse strain with the FoxG1-gene targeted by Cre-
recombinase (Cre). Mice were maintained as heterozygotes as homozygotes are not viable 
postnatally. (2,15).  
3.3 Genotyping 
All embryos were genotyped, from liver samples or tail samples using primers for FoxG1 
and Cre. DNA was extracted by a fast extraction – method: incubated in 95°C for one hour 
in 75µl of alkaline lysis reagent (NaOH 0.5g; Na2-EDTA 2H20 0.03722g; pH~12), after 
incubation samples were cooled on ice and 75µl of neutralizing reagent (Tris-HCl 3.152g, 
pH~5) was added and samples were ready for PCR. PCR was conducted with Thermo 
Fischers Dynazyme buffer and Dynazyme II polymerase. Primers used: FoxG1-F 
GAACGGCAAGTACGAGAAGC, FoxG1-R TCACGAAGCACTTGTTGAGG product 
197 base pairs; Cre-F AATCTCCCACCGTCAGTACG, Cre-R 
CGTTTTCTGAGCATACCTGGA product 472 base pairs. 
3.4 Immunohistochemical staining of Neural crest cells 
In embryonic development the bones of the face, the frontal bones and the anterior part of 
the skull base are formed by the neural crest cells (NCC) (4,16). In this study, NCC’s were 
mapped at embryonic (E) days 10.5 and 12.5 using a beta-1,3-glucuronyltransferase 1 
(HNK1)-antibody. HNK1- is an early NCC-marker (16). FoxG1cre/cre-embryos (MT) were 
compared to FoxG1+/+-embryos (WT) to see if there is a difference in the migration and 
mapping of the NCC’s. The whole embryos were fixed in 4%-paraformaldehyde (PFA)-
solution overnight and dehydrated in rising methanol series. The embryos were rehydrated 
in a rising methanol series, washed with Tris Buffered Saline-Tween (0.1%) – solution 
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(TBST). After this the endogenous peroxidase activity was diminished by incubating the 
embryos in 6% hydrogen peroxide solution in TBST for 30 minutes in room temperature 
(RT) and washed in TBST after. Then the embryos were treated with proteinase K 10g/ml 
solution in TBST for 20 minutes in RT and washed with TBST. Embryos were then blocked 
in a solution containing 5% bovine serum albumin (BSA) and 3 % fetal bovine serum in 
TBST overnight at 6°C. Then the embryos were incubated with the primary antibody (HNK1) 
1:1000 in TBST with 3% BSA overnight at 6°C and washed with TBST. After this the 
embryos were incubated over night at 6°C with the secondary antibody 1:1000 in TBST with 
3% BSA, which was horseradish peroxidase – fluorescent conjugated (provided in the 
EnzMet™ -kit). Then the embryos were treated according to EnzMet™ HRP Detection Kit 
for IHC / ISH, and imaged. 
3.5 EDU proliferation assay 
The proliferation of cells was detected by an 5-ethynyl-2'-deoxyuridine (EDU)-assay. Time-
mated females were injected intraperitoneally with EDU 100µl, 10mg/ml, 5µl/g. two hours 
before harvesting embryos. Embryos were dissected, keeping only the heads, fixed overnight 
in a 4%-paraformaldehyde (PFA)-solution, dehydrated in a rising ethanol series and xylene 
and embedded in paraffin. After embedding the tissues were sectioned at 7µm intervals. 
Sections were deparaffinated in xylene and rehydrated in a rising ethanol series 100%, 95% 
and 80 % for 10 minutes each. Sections were rinsed in deionized water and washed with 
2mg/ml glycine-solution. After washing sections were permeabilized with 0,5% Triton X-
100 in Dulbecco's phosphate-buffered saline (PBS) (pH 7.3) for 20 minutes and washed with 
PBS twice for 10 minutes. Sections were incubated in Click-iT ™ reaction- cocktail in 
darkness for 30 minutes and rinsed twice with PBS for 10 minutes. DNA-staining was also 
conducted with Hoechst 33342 5µl/ml in PBS - solution also incubated for 30 minutes in 
darkness. After incubation sections were washed with PBS twice for three minutes and 
mounted with Immumount™. EDU-proliferation assays were made to embryos aged E13.5 
and E15.5 to see if there is a difference in the proliferation of cells in MT-embryos compared 
to the cells in WT-embryos. The cells were calculated from 20x magnification on an area of 
1cm2. The ratio between cells that are dividing, and all cells were calculated. 
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3.6 In situ-hybridisations 
Probe template was generated from a plasmid containing the FoxG1 m-RNA, by PCR from 
an MGC cDNA (accession BC046958) using primers, lower case letter indicates the phage 
promoter: FoxG1F AGT TAC AAC GGG ACC ACG TC and FoxG1R-T3 
aattaaccctcactaaagg CCCTGATTTTGATGTGTGA. cDNA-clone was processed to 
antisense(AS) and sense (S) – coding templates with primers: AS FoxG1-F-T7 
TAATACGACTCACTATAGGGAGTTACA ACGGGACCA CGTC, FoxG1-T7R 
GAAGACCCCTGATTTTGATGTGTG; S FoxG1-F1 AGTTACAACGGGACCACGTC, 
FoxG1-T3 R AATTAACCCTCACTAAAGGCCCCTGATTTTGATGTGTGA. The 
transcription template was generated from the cDNA clone using T3 and T7 primers and 
labelled with digoxigenin (DIG). (17) 
DIG – labelled FoxG1- mRNA-probe was made and a paraffin section in situ-hybridisation 
was conducted to embryo heads aged E12.5 WT-embryos. It was shown that FoxG1 is 
expressed only in the brain, not in the skull as shown previously. (2,15,16) Whole mount in 
situ-hybridisations were made WT-embryos aged E9.5, E10.5 and E12.5 to map out the 
expression patterns of FoxG1, using the same mRNA-probes. (17)  
3.7 Skeletal preparations 
Skeletal preparations were made of embryos aged E15.5, E18.5 and new born pups (NB), to 
show the phenotype. The skeletons were stained with Alcian blue, which stains the cartilage 
and Alizarin red, which stains the mineral/bone. Embryos were fixed overnight in 95% 
ethanol in 20ml scintillation vials, after removing the skin. After fixation the embryos were 
incubated in one volume glacial acetic acid and four volumes 95% ethanol and 7,5 mg/50ml 
Alcian blue for 48 hours. After incubation embryos were rinsed in 95% ethanol for one hour 
and incubated in 2% potassium hydroxide (KOH)-solution (E15.5 for one hour, E18.5 and 
NB for 6 hours). 2%KOH-solution was replaced by 1%KOH solution with 75µg/ml Alizarin 
red and incubated overnight. After these incubations embryos were cleared for a week in 
20% glycerol-1%KOH – solution. For storage embryos were transferred to 50%glyserol-
50%ethanol – solution. 
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3.8 Micro computed tomography (µCT)  
Micro CT is three-dimensional x-ray imaging. NB embryo heads were fixed in an ethanol 
series and embedded in an agarose gel. The system used in the scanning was Bruker’s 
scanner: SkyScan1272 and the software version was 1.1.1. The imaging parameters were: 
Camera Pixel Size (µm) = 9.0, Camera X/Y Ratio: 1.0118, Source Voltage (kV) = 60, Source 
Current (µA)= 166, Reference Intensity=57000, Exposure (ms)=512, Rotation Step 
(degrees)=0.300. 
3.9 Statistical analysis 
P-values were calculated with a paired t-test and p<0.05 was considered statistically 
significant and p<0.001 considered to be statistically highly significant. 
4 Results 
4.1 Foxg1cre/cre mutant mice exhibit nasal and frontal bone abnormalities 
In the skeletal preparations was found that there is a skull phenotype in the Foxg1cre/cre mutant 
embryos (MT) compared to wild type (WT) litter mates. (Figure 1.) The rest of the skeleton 
was unaffected.  
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Figure 1. FoxG1cre/cre mice exhibit skeletal defects in the nasal and frontal bones. Alcian 
blue/Alizarin red – staining of Foxg1 +/+ - embryos (a) A-I) Foxg1 cre/cre - embryos (a) J-R). 
A, D, F, J, M and P is showing the side image of the stained skulls, in MT-embryos the maxilla 
appears retruded compared to the mandible, as in the WT-embryos the maxilla and mandible 
are well balanced. B, E, H, K, N and Q is showing the calvaria, dotted black lines in N and 
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Q indicate the unusual shape of the nasal bones, which are narrower than in the WT-embryos 
E and H. C, F, I, L, O and R is showing the calvaria, dotted black lines in O and R indicate 
the star shape of the suture, in F and I the WT-embryos suture doesn’t have the star shape. 
b) and c) illustrates the measurements shown as a percentage of MT/WT. Single asterisk 
indicate the statistical significance of p<0.05, and two asterisks indicates the statistical 
significance of p<0.001, error bars indicate standard error. The scale bar in all the pictures 
is 0.5mm.  Magnifications in A, D, F, J, M, Q, B, E, H, K, N and Q is 1.25; in C and L 3.2; 
in F, I, O and R 2.5.  f=frontal bone, ip=inter parietal bone, n=nasal bone, man=mandible, 
max=maxilla, p=parietal bone. 
A series of measurements was conducted from the skeletal preparation images. It was found 
that the skull was slightly shorter in the MT-embryos compared to the WT-embryos. Also, 
the anterior part of the skull base, nasal bone width and the frontal bone minimum width were 
smaller in the MT-embryos. (Figure 1 a) and b)) A p-value of 0.05 was considered 
statistically significant and it was calculated with a paired t-test. Measurements are seen in 
figure 1 b) and c) as a percentage of MT compared to WT. Whole skull is measured from the 
anterior tip of the nasal bone to the posterior tip of occipital bone (occiput) and the p-values: 
E18.5 4.8*10^-10, NB 0.002. Skull base anterior:  E18.5 p-value 0.2 and Skull base posterior: 
E18.5 p-value 0.2. Minimum width of frontal bones: E18.5 p-value 1.7*10^-09, NB p-value 
0.001. Nasal bone length: E18.5 p-value 0.2, NB p-value 0.08. Minimum width of nasal 
bones: E18.5 p-value 1.1*10^-06, NB p-value 0.005. Mandible width: E18.5 p-value 0.8 and 
mandible length: E18.5 p-value 0.06. Maxilla length: E18.5 p-value 0.07, NB p-value 0.9.  
Statistically significant difference between mutant, and wild type at ages E18.5 and NB in 
whole skull size, frontal bone width and nasal bone. The number of embryos in the age E18.5 
is 10 MT and seven WT. The number of embryos in NB’s was four MTs and three WTs. 
Differences seen in alizarian red/alcian blue stainings was also seen in the µCT-images 
(Figure 2) The nasal bones, skull base and the frontal bones are affected by the loss of 
FOXG1. In addition, another abnormality in the frontal bones was found in the µCT-images. 
The frontal bones in the MT-embryos are two layered (Figure 2 J). 
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Figure 2. Nasal bone and frontal bone phenotype of Foxg1cre/cre-embryos. µCT – images of 
NB-embryos of MT Foxg1 cre/cre - embryos (F-J) and WT Foxg1 +/+ - embryos (A-E). A, B, F 
and G are showing the nasal bones. C and H are showing the skull bases. D. E, I and J are 
showing the frontal bones. The arrows in J are illustrating the frontal bone phenotype: in the 
MT the bone is in two layers as in the WT (E) the bone is one layered. f=frontal bone, n=nasal 
bone, max=maxilla. 
4.2 Foxg1 mRNA is not expressed in the developing frontal bone 
Foxg1 mRNA was detected by in situ-hybridisation in the developing brain and limbs (Figure 
3). Despite Foxg1cre/cre mutation the mice exhibit a frontal bone. Phenotype Foxg1 was not 
detected in the frontal bone primordia at E12.5. FOXG1 was however expressed in the other 
cells of the forebrain. A location adjacent to calvarial mesenchyme into which the frontal 
bone will develop. This directs to the hypothesis that possible forebrain calvarial 
mesenchyme tissue-tissue interactions may regulate frontal bone development. 
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Figure 3. FoxG1 is expressed in the forebrain and limbs of NMRI-WT-mice. A and B is 
showing whole mount in situ-hybridisation of FoxG1 antisense mRNA-probe in NMRI-WT 
mice E11.5 and E12.5. Scale bar 0.5mm. Arrows indicate the expression present in the 
forebrain area, and in the fore and hind limbs. C-E Expression pattern of FoxG1 on paraffin 
section at E12.5 Foxg1 +/+ - embryo with 4x magnification in C), 10x magnification in D) 
and E). C) Shows the frontal section of the embryo upper ellipse is showing the magnification 
point of E) and the lower ellipse is showing the magnification point of D). D) The area with 
the asterisk is showing the frontal bone, which doesn’t have any expression of FoxG1. E) The 
arrowheads are marking the expression in the brain, but the expression is not seen in the 
surface structures.  
A whole mount in situ-hybridisation was also conducted and it was found that the expression 
pattern was as shown before: in the limbs and brain. (Figure 4.) 
4.3 Increased expression of neural crest cell marker HNK1 in Foxg1 cre/cre mutant mice 
FOXG1 is known to be expressed in cranial NCC’s. To test whether NCC distribution is 
altered in Foxg1cre/cre mutants, whole mount samples from Foxg1 cre/cre and WT littermates 
were stained by immunohistochemistry for the NCC marker HNK1 at key stages of NCC 
migration (E9.5-E12.5). In the HNK1- antibody staining a difference was seen in the 
expressions. It was found that in the earlier stages (E9.5) of the migration of the NCC’s there 
11 
                      
 
is slightly more expression seen in the MT-embryos. At E10.5 there seems to be more 
expression in the WT and then in the E12.5 embryos there is an obvious difference in the 
MT-embryos compared to the WT-embryos. The E12.5 expression difference is significantly 
seen in the facial area. 
 
Figure 4. The expression of HNK1, a NCC-marker, in Foxg1 cre/cre (MT) - and Foxg1 +/+ (WT) 
-embryos. All the pictures illustrate whole mount HNK1-Immunohistochemical staining. The 
arrows in B, C mark the difference in the WT- embryos compared to K, L MT-embryos at 
E9.5. It is seen that, the expression in the MT (K) is only in eight vertebrae as in the WT (B) 
the expression is in 10. There is a difference also in the expression in the back of the 
developing head. The arrows in C and L indicate the difference, in the MT (L) the pattern is 
wider and, in the WT (C), the pattern is more stricted and darker.  The arrows in E and N 
show the difference at E 10.5, there is less expression in the MT (N) than in the WT (E). Then 
in the E12.5 the expression in the MT (Q and R) is significantly wider and stronger than in 
the WT (H and I). 
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4.4 Proliferation in Foxg1cre/cre mutant mice 
In the EDU-proliferation assay there were no significant differences found between MT- and 
WT-embryos. The cells were calculated with a fixed area and the area was chosen to be the 
caudal part of the developing frontal bone (Figure 5). 
 
Figure 5. There seems to be no difference in the proliferation of cells in Foxg1 cre/cre (MT) -
embryos compared to the Foxg1 +/+ (WT) -embryos. a) Is showing a frontal sections of WT 
(A) and MT (B). The rectangles indicate the placement of calculated cells. b) shows the ratio 
between proliferating cells divided with the amount of all cells at ages E13.5 and E15.5, 
error bars indicate standard error. 
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5 Discussion 
5.1 Introduction 
Craniofacial development is a complex process which involves many tissue interactions and 
signaling pathways. The consequences of disruption of these processes can cause many 
different craniofacial abnormalities. (18) 
In this study we report that frontal bone development is affected Foxg1cre/cre mutant mice. 
The tissue affected arises from the neural crest cells (NCC’s). (5) 
5.2 Key findings 
In late embryonic stages the frontal bones approximate each other, the frontal suture narrows, 
and the anterior fontanelle reduces in size, however in Foxg1 null allele mutants there is an 
enlargement of this suture and frontanelle. There also was an abnormal shape in the in frontal 
suture of the Foxg1 cre/cre (MT) – embryos. It was also revealed that the frontal bones of the 
MT-embryos were curved/two layered and the frontal bones were narrower than in the Foxg1 
+/+ (WT)-littermates. The skull was shorter in the in MT-embryos compared to the in (WT) 
littermates.  The MT-embryos had also narrower nasal bones.  
It was seen in the in situ-hybridisations that FOXG1 is expressed in the forebrain, but not in 
the developing calvaria, as was shown before. (8,9,10) The expression of FOXG1 was also 
seen in the fore and hind limbs of the mice. This expression pattern leads to the hypothesis, 
that forebrain – calvarial mesenchyme tissue-tissue interactions may regulate the developing 
frontal bone. Interactions between the developing brain and calvaria have been suggested 
previously to regulate calvarial osteogenesis. (19) Signals from the dura mater are known to 
regulate calvarial suture pattern. (20,21) 
The affected area is in the region of NCC’s. In the NCC marker HNK1- antibody stainings a 
difference was seen in the expressions between MT and WT-littermates. It was found that in 
the earlier stages (E9.5) of the migration of the NCC’s there is slightly more expression seen 
in the MT-embryos. At E10.5 there seems to be more expression in the WT. At the age of 
E12.5, the expression has an obvious difference in the MT-embryos compared to the WT-
embryos. The area that has the most expression is the facial area, that gives rise to the 
structures that have abnormalities in the MT-embryos. It has been shown that alterations in 
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calvarial cell proliferation can result in delayed osteogenesis and enlarged sutures (15). 
However, Foxg1 cre/cre mice did not show proliferation abnormalities in the areas assayed, 
which could count for the abnormalities seen. Therefore, the hypothesis that the migration of 
the NCC’s is affected by the lack of FOXG1, would need more experimentation to be 
verified. 
Results described here have allowed to be speculated that the frontal bone phenotype 
exhibited by Foxg1cre/cre mice may be the result of alteration in NCC migration or further 
and/or for disruption of tissue-tissue interaction between the developing brain and the 
calvarial mesenchyme. Within the presented framework it is limited to these two hypotheses.   
5.3 Significance 
In humans, mutations in the gene coding FOXG1 cause Foxg1-syndrome, which is a Rett-
syndrome like disorder that effects many different parts of the development of head 
structures. These include: postnatal microcephaly, severe mental retardation, absent 
language, dyskinesia and corpus callosum hypogenesis. (1) Although relevantly few FOXG1- 
syndrome patients have been documented more are being described and knowledge of the 
craniofacial phenotype in mice mutants: abnormal shape and enlargement of the frontal 
suture and frontanelle, may be useful to patients and diagnosing clinicians. (22) 
5.4 Conclusions 
A difference between the MT and WT embryos was found in the skull. The frontal suture 
developed into an abnormal shape, and the frontal bones formed into two-layered/curved and 
were narrower. Also, the width of the nasal bones of the MT-embryos were significantly 
narrower than in the WT-embryos. The proliferation assay did not show a statistically 
relevant difference in the proliferation of the cells which leads to the assumption that 
abnormalities observed in NCC’s may explain, at least in part, the phenotype described. 
Verification of this hypothesis and integration with signaling pathways in which FOXG1 is 
known to act, including WNT-signaling, will need further investigation. (11,17) 
The mouse’s frontal suture equivalent in humans is the metopic suture and it is normally 
fused in the first year after birth. Knowledge of the phenotype in Foxg1cre/cre mice will be of 
interest, not only to investigators studying craniofacial development, but also to patients with 
FOXG1-mutations and their attending clinicians. If similar defects seen in Foxg1cre/cre mice 
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were detected in patients, steps may be taken to protect the brain underlying an abnormally 
large interfrontal/metopic suture. (23,24) 
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